Litigation

Recent Posts

Vermont Prescription Drug Data Mining Law Struck Down
Posted on 24 Jun 2011 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. - (AP) States cannot stop drug manufacturers and data-mining companies from using information about the prescription drugs individual doctors like to prescribe, the Supreme Court ruled Thursday. The court voted 6-3 to strike down a Vermont... Read More

Tags: Supreme Court , health care , Sorrell v. IMS Health , Vermont , Privacy , Litigation , First Amendment , prescription drugs , data mining , free speech , prescriptions

Glaxo To Plead Guilty, Will Pay $3 Billion Stemming From Drug Marketing
Posted on 2 Jul 2012 by Tom Moylan

BOSTON - (Mealey's) GlaxoSmithKline LLC (GSK) agreed June 2 to plead guilty and to pay $3 billion to resolve broad-ranging criminal and civil allegations in Massachusetts federal court regarding the promotion of several prescription drugs, failure... Read More

Tags: diabetes drug , Lotronex , Wellbutrin , drugs , GlaxoSmithKline LLC , False Claims Act , United States ex rel. Greg Thorpe v. GlaxoSmithKline PLC , Imitrex , Valtrex , Paxil , antidepressants , United States of America v. GlaxoSmithKline LLC , U.S. Department of Justice , U.S. Food and Drug Administration , Litigation , GSK , Flovent , prescription drugs , Avandia

Arizona High Court Adopts Learned Intermediary Doctrine; No Conflict With Tort Law
Posted on 21 Jan 2016 by Tom Moylan

PHOENIX — (Mealey’s) The Arizona Supreme Court on Jan. 21 adopted the learned intermediary doctrine and said it can be used by drug manufacturer Medicis Pharmaceutical Corp. to defend against a drug liability claim ( Amanda Watts v. Medicis... Read More

Tags: drugs , learned intermediary doctrine , Arizona Consumer Fraud Act , Amanda Watts , Medicis Pharmaceutical Corp. , Amanda Watts v. Medicis Pharmaceutical Corporation , drug liability , Arizona Supreme Court , acne , Litigation , Solodyn , prescription drugs , torts , tetracycline

FDA Removes More Than 500 Unapproved Cough, Cold And Allergy Drugs
Posted on 2 Mar 2011 by Tom Moylan

ROCKVILLE, Md. - (Mealey's) The Food and Drug Administration on March 2 announced that it is requiring drug manufacturers to take more than 500 prescription cough, cold and allergy drugs off the market because they are unapproved. The drugs... Read More

Tags: pseudoephedrine , drugs , clorpheniramine , drug manufacturers , Food and Drug Administration , dextromethorphan , cold and allergy drugs , FDA , guaifenesin , Litigation , cough drugs , lawsuit , prescription drugs